Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DIAGNOSTIC AND PROGNOSTIC PERFORMANCE OF POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN EOSINOPHILIC FASCIITIS: AN OBSERVATIONAL MULTICENTER RETROSPECTIVE STUDY.
Chevalier K, Bouaziz JD, Groh M, Allali D, Belfeki N, Bourse N, Cazalets-Lacoste C, Collot R, Flamarion E, Lacombe V, Le Scornet T, Mauhin W, Michaud M, Dupin N, Kahn JE, Mouthon L, Chaigne B. Chevalier K, et al. Among authors: dupin n. J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03242-0. doi: 10.1016/j.jaad.2024.11.031. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39579994 No abstract available.
Favorable prognosis of subcutaneous sarcoidosis: French cohort of 80 patients compared with dermal sarcoidosis.
Chauffier J, Chasset F, Battistella M, Jachiet M, Vignon Pennamen MD, Cohen E, Dupin N, Lheure C, Begon E, Bessis D, de Masson A, Jachiet V, Gottlieb J, Teboul A, Bergeret B, Brenaut E, Debarbieux S, Gazengel P, Tazi A, Nunes H, Bouaziz JD, Mahévas T; Groupe d’étude des maladies systémiques en dermatologie (EMSED). Chauffier J, et al. Among authors: dupin n. J Am Acad Dermatol. 2024 Oct 12:S0190-9622(24)02995-5. doi: 10.1016/j.jaad.2024.07.1532. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39401610 No abstract available.
Syphilis testing in blood donors, France, 2007 to 2022.
Laperche S, Sauvage C, Le Cam S, Lot F, Malard L, Gallian P, Pouchol E, Richard P, Morel P, Grange P, Tiberghien P, Benhaddou N, Dupin N. Laperche S, et al. Among authors: dupin n. Euro Surveill. 2024 Aug;29(32):2400036. doi: 10.2807/1560-7917.ES.2024.29.32.2400036. Euro Surveill. 2024. PMID: 39119720 Free PMC article.
Early neurosyphilis with serofast state.
Zayet S, Poloni S, Gendrin V, Chanal J, Dupin N, Klopfenstein T. Zayet S, et al. Among authors: dupin n. Emerg Microbes Infect. 2024 Dec;13(1):2373305. doi: 10.1080/22221751.2024.2373305. Epub 2024 Jul 16. Emerg Microbes Infect. 2024. PMID: 38922299 Free PMC article.
Isotretinoin: Past, present and future. A French perspective.
Leducq S, Poizeau F, Chaby G, Tannous J, Ballanger-Desolneux F, Baubion E, Bertolotti A, Cogrel O, Droitcourt C, Garnier V, Gautier S, Hefez L, Hotz C, Jonville-Béra AP, Jouan N, Mahé A, Mahé E, Martinho G, Micallef J, Puszkarek T, Dupin N, Ly S, Beylot-Barry M, Corgibet F, Guillot B, Chosidow O; Centre of Evidence of the French Society of Dermatology, the DErmatoses FacIales group of the French Society of Dermatology. Leducq S, et al. Among authors: dupin n. Ann Dermatol Venereol. 2024 Sep;151(3):103244. doi: 10.1016/j.annder.2023.103244. Epub 2024 Jun 7. Ann Dermatol Venereol. 2024. PMID: 38848643 No abstract available.
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.
Molina JM, Bercot B, Assoumou L, Rubenstein E, Algarte-Genin M, Pialoux G, Katlama C, Surgers L, Bébéar C, Dupin N, Ouattara M, Slama L, Pavie J, Duvivier C, Loze B, Goldwirt L, Gibowski S, Ollivier M, Ghosn J, Costagliola D; ANRS 174 DOXYVAC Study Group. Molina JM, et al. Among authors: dupin n. Lancet Infect Dis. 2024 Oct;24(10):1093-1104. doi: 10.1016/S1473-3099(24)00236-6. Epub 2024 May 23. Lancet Infect Dis. 2024. PMID: 38797183 Clinical Trial.
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Cohen E, et al. Among authors: dupin n. Eur J Dermatol. 2023 Dec 1;33(6):680-685. doi: 10.1684/ejd.2023.4584. Eur J Dermatol. 2023. PMID: 38465550
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: dupin n. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Clinical Trial.
480 results